Department of Obstetrics and Gynaecology

Lessons learned from a candidate gene study investigating aromatase inhibitor treatment outcome in breast cancer (2025) Hoppe R, Winter S, Lo WY, Michailidou K, Bolla MK, Keeman R, Wang Q, et al. Journal article A case of metachronous cervical and early-stage breast cancer (2025) Iason P, Emons J, Burghaus S, Paul G, Stübs F, Seibold A, Füller A, et al. Journal article Atezolizumab Monotherapy Window Preceding Combined Neoadjuvant Chemotherapy and Immune Therapy in Triple-Negative Breast Cancer-The neoMono Trial (2025) Kolberg HC, Schumacher J, Erber R, Braun M, Fasching P, Grischke EM, Schem C, et al. Journal article Association of prenatal alcohol exposure and prenatal depressive symptoms with offspring hair cortisol in childhood and adolescence (2025) Plank AC, Panaseth-Gehle K, Gerlach J, Mestermann S, Fasching P, Beckmann M, Kratz O, et al. Journal article Study Protocol of SURVIVE HERoes (NCT06643585): Trastuzumab Deruxtecan for molecular relapse in HER2+/ Low early breast cancer with ctDNA positivity after primary therapy (2025) Pfister K, Friedl TW, Hartkopf A, Mergel F, Huesmann S, Mehmeti F, Schäffler H, et al. Journal article Adjuvant ribociclib plus nonsteroidal aromatase inhibitor therapy in patients with HR-positive/HER2-negative early breast cancer: 5-year follow-up of NATALEE efficacy outcomes and updated overall survival (2025) Crown J, Stroyakovskii D, Yardley DA, Huang CS, Fasching P, Bardia A, Chia S, et al. Journal article AGO Breast Commission recommendations for the surgical therapy of breast cancer: Working Group on Gynecologic Cancers (AGO) update 2025 (2025) Reimer T, Kuehn T, Mueller V, Ditsch N, Fehm T, Albert US, Bartsch R, et al. Journal article, Review article Cross-sectional study on user requirements for developing a digital patient navigator app (2025) Seitz K, Langbein M, Goossens C, Altmannshofer S, Fasching P, Hack C, Heindl F, et al. Journal article Virtual contrast-enhanced maximum intensity projections from high-b-value diffusion-weighted breast MRI: a feasibility study (2025) Liebert A, Schreiter H, Hadler D, Kapsner L, Ohlmeyer S, Eberle J, Erber R, et al. Journal article Ribociclib Plus Endocrine Therapy in Hormone Receptor-Positive/ERBB2-Negative Early Breast Cancer: 4-Year Outcomes From the NATALEE Randomized Clinical Trial (2025) Fasching P, Stroyakovskiy D, Yardley DA, Huang CS, Crown J, Bardia A, Chia S, et al. Journal article